Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Lentivirus | 4 | 2021 | 310 | 0.44 | Why? |
| Antibodies, Neutralizing | 13 | 2021 | 25288 | 0.29 | Why? |
| Antibodies, Viral | 19 | 2021 | 51949 | 0.27 | Why? |
| Neutralization Tests | 8 | 2021 | 6698 | 0.23 | Why? |
| Orthomyxoviridae Infections | 2 | 2018 | 1001 | 0.21 | Why? |
| Mutagenesis | 1 | 2021 | 394 | 0.18 | Why? |
| Viral Core Proteins | 1 | 2018 | 134 | 0.17 | Why? |
| Antibodies, Monoclonal | 5 | 2021 | 8041 | 0.15 | Why? |
| Herpesvirus 2, Human | 1 | 2017 | 137 | 0.15 | Why? |
| Spike Glycoprotein, Coronavirus | 12 | 2021 | 37182 | 0.13 | Why? |
| Herpesvirus 1, Human | 1 | 2017 | 286 | 0.13 | Why? |
| Cross Reactions | 3 | 2021 | 4374 | 0.13 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2018 | 511 | 0.13 | Why? |
| Herpes Simplex | 1 | 2017 | 272 | 0.13 | Why? |
| Immunohistochemistry | 1 | 2020 | 2275 | 0.12 | Why? |
| Influenza Vaccines | 2 | 2018 | 2941 | 0.11 | Why? |
| Vaccines, Inactivated | 1 | 2018 | 1562 | 0.11 | Why? |
| Genetic Vectors | 1 | 2018 | 1600 | 0.11 | Why? |
| Vaccines, Synthetic | 2 | 2021 | 3231 | 0.11 | Why? |
| Blood Donors | 2 | 2020 | 2956 | 0.10 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.10 | Why? |
| Transfection | 2 | 2021 | 864 | 0.09 | Why? |
| Plasmids | 2 | 2021 | 840 | 0.09 | Why? |
| Point-of-Care Testing | 1 | 2020 | 2782 | 0.08 | Why? |
| SARS Virus | 3 | 2020 | 13021 | 0.08 | Why? |
| Evolution, Molecular | 1 | 2021 | 3691 | 0.08 | Why? |
| Membrane Glycoproteins | 2 | 2007 | 2273 | 0.08 | Why? |
| Influenza A virus | 1 | 2018 | 2234 | 0.08 | Why? |
| B-Lymphocytes | 1 | 2021 | 4418 | 0.08 | Why? |
| Leukemia Virus, Murine | 1 | 2005 | 38 | 0.08 | Why? |
| CD13 Antigens | 1 | 2007 | 232 | 0.07 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2008 | 12361 | 0.07 | Why? |
| Th2 Cells | 1 | 2008 | 680 | 0.07 | Why? |
| Immunization, Passive | 4 | 2021 | 10067 | 0.07 | Why? |
| Enzyme-Linked Immunosorbent Assay | 4 | 2021 | 7868 | 0.07 | Why? |
| Vero Cells | 4 | 2021 | 14117 | 0.07 | Why? |
| Cell Line | 4 | 2021 | 12040 | 0.07 | Why? |
| Immunity, Cellular | 1 | 2017 | 3614 | 0.07 | Why? |
| Viral Envelope Proteins | 2 | 2007 | 3539 | 0.06 | Why? |
| Population Surveillance | 1 | 2020 | 4967 | 0.06 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.06 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.06 | Why? |
| HEK293 Cells | 3 | 2021 | 8394 | 0.06 | Why? |
| Animals | 10 | 2021 | 78931 | 0.06 | Why? |
| Mice | 5 | 2021 | 21357 | 0.06 | Why? |
| Immunologic Memory | 2 | 2018 | 3362 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.06 | Why? |
| 3T3 Cells | 1 | 2021 | 152 | 0.06 | Why? |
| RNA Probes | 1 | 2020 | 106 | 0.05 | Why? |
| Coronavirus, Feline | 1 | 2007 | 581 | 0.05 | Why? |
| Immune Evasion | 2 | 2021 | 2081 | 0.05 | Why? |
| Vesiculovirus | 1 | 2020 | 153 | 0.05 | Why? |
| Mutant Proteins | 1 | 2021 | 328 | 0.05 | Why? |
| Virus Attachment | 1 | 2007 | 1259 | 0.05 | Why? |
| Binding Sites, Antibody | 1 | 2021 | 466 | 0.05 | Why? |
| Sensitivity and Specificity | 4 | 2021 | 22971 | 0.05 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 2 | 2021 | 8843 | 0.05 | Why? |
| Antigen-Antibody Complex | 1 | 2021 | 408 | 0.05 | Why? |
| Seroepidemiologic Studies | 3 | 2020 | 10017 | 0.05 | Why? |
| In Situ Hybridization | 1 | 2020 | 390 | 0.05 | Why? |
| Integrases | 1 | 2018 | 17 | 0.05 | Why? |
| CHO Cells | 1 | 2021 | 831 | 0.05 | Why? |
| Cricetulus | 1 | 2021 | 936 | 0.04 | Why? |
| Geography, Medical | 1 | 2020 | 537 | 0.04 | Why? |
| Inhibitory Concentration 50 | 1 | 2020 | 907 | 0.04 | Why? |
| Longitudinal Studies | 2 | 2020 | 9893 | 0.04 | Why? |
| Enzyme-Linked Immunospot Assay | 1 | 2018 | 325 | 0.04 | Why? |
| Disease Models, Animal | 3 | 2021 | 10998 | 0.04 | Why? |
| Immunoglobulin Fc Fragments | 1 | 2021 | 691 | 0.04 | Why? |
| Models, Molecular | 2 | 2021 | 7616 | 0.04 | Why? |
| Scotland | 1 | 2020 | 1119 | 0.04 | Why? |
| Protein Structure, Tertiary | 1 | 2021 | 1565 | 0.04 | Why? |
| Immune Sera | 1 | 2020 | 884 | 0.04 | Why? |
| Immune Tolerance | 1 | 2021 | 608 | 0.04 | Why? |
| Dose-Response Relationship, Immunologic | 1 | 2017 | 593 | 0.04 | Why? |
| Coronavirus NL63, Human | 1 | 2021 | 669 | 0.04 | Why? |
| Male | 12 | 2021 | 367725 | 0.04 | Why? |
| Models, Immunological | 1 | 2020 | 727 | 0.04 | Why? |
| Ferrets | 1 | 2020 | 1201 | 0.04 | Why? |
| Female | 12 | 2021 | 380317 | 0.03 | Why? |
| Species Specificity | 1 | 2018 | 1356 | 0.03 | Why? |
| Organ Specificity | 1 | 2018 | 1070 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2021 | 2689 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2021 | 2739 | 0.03 | Why? |
| Coronavirus OC43, Human | 1 | 2021 | 1157 | 0.03 | Why? |
| Coronavirus 229E, Human | 1 | 2021 | 1241 | 0.03 | Why? |
| Humans | 17 | 2021 | 930598 | 0.03 | Why? |
| Kinetics | 1 | 2020 | 3238 | 0.03 | Why? |
| Cluster Analysis | 1 | 2020 | 3001 | 0.03 | Why? |
| Coronavirus | 1 | 2021 | 18339 | 0.03 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2008 | 5837 | 0.03 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.03 | Why? |
| Adenoviridae | 1 | 2017 | 1151 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2018 | 1387 | 0.03 | Why? |
| Vaccines, DNA | 1 | 2017 | 871 | 0.03 | Why? |
| Aged | 6 | 2021 | 215776 | 0.03 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.03 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.03 | Why? |
| Receptors, Virus | 1 | 2007 | 5659 | 0.03 | Why? |
| Urban Population | 1 | 2020 | 2000 | 0.03 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.02 | Why? |
| Lysosomal-Associated Membrane Protein 1 | 1 | 2008 | 27 | 0.02 | Why? |
| Immunization | 1 | 2018 | 2019 | 0.02 | Why? |
| Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2008 | 58 | 0.02 | Why? |
| Protein Binding | 2 | 2021 | 11430 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3633 | 0.02 | Why? |
| Leukocyte Common Antigens | 1 | 2008 | 101 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Epitopes | 1 | 2021 | 4113 | 0.02 | Why? |
| Protein Domains | 1 | 2021 | 6563 | 0.02 | Why? |
| Drug Delivery Systems | 1 | 2018 | 1365 | 0.02 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.02 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2018 | 2585 | 0.02 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Transduction, Genetic | 1 | 2007 | 273 | 0.02 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2020 | 3388 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Chronic Disease | 1 | 2021 | 5139 | 0.02 | Why? |
| Green Fluorescent Proteins | 1 | 2007 | 450 | 0.02 | Why? |
| Genes, Reporter | 1 | 2007 | 472 | 0.02 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.02 | Why? |
| Adult | 5 | 2020 | 244371 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Italy | 2 | 2020 | 38444 | 0.02 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2021 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.02 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.02 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.01 | Why? |
| Immunity, Humoral | 1 | 2017 | 4849 | 0.01 | Why? |
| Cytokines | 2 | 2018 | 15010 | 0.01 | Why? |
| Viral Vaccines | 2 | 2017 | 7560 | 0.01 | Why? |
| Phylogeny | 1 | 2021 | 13341 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Vaccination | 2 | 2018 | 19050 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Immunogenicity, Vaccine | 1 | 2017 | 4624 | 0.01 | Why? |
| Cats | 1 | 2007 | 1890 | 0.01 | Why? |
| Genome, Viral | 1 | 2021 | 13157 | 0.01 | Why? |
| Flow Cytometry | 1 | 2007 | 2393 | 0.01 | Why? |
| Proteome | 1 | 2008 | 1812 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.01 | Why? |
| Child | 1 | 2005 | 70012 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| Adolescent | 1 | 2005 | 86841 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2018 | 21571 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Pregnancy Complications, Infectious | 1 | 2017 | 11559 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Cohort Studies | 1 | 2008 | 36005 | 0.00 | Why? |
Temperton's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(155)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(395)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_